SASeyed Sahab Aarabi

Seyed Sahab Aarabi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyed Sahab Aarabi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Economic drivers and systemic disparities in invasive coronary angiography: Insights from a national claims database

    by Seyed Sahab Aarabi, Farbod Semnani, Kiavash Semnani, Shirin Esmaeili, Rajabali Daroudi, Mehdi Rezaei, Mohammad Effatpanah, Mohamad Mehdi Nasehi, Majid Haghjoo

    Background: Despite the prominent economic burden of coronary care, detailed analyses of factors associated with expenditure in developing nations remain sparse. Objectives: This study aimed to provide such analyses using data from a national cohort of patients undergoing invasive coronary angiography (ICA). Methods: Patient data and billable services were retrieved from the Iran Health Insurance Organization (IHIO) database. Data from 158584 hospitalizations were analyzed. A multi-pollutant index was constructed using weighted quantile sum regression. Hospital case volume and provincial ICA rates were modeled using generalized linear models. Three-tier (patient, hospital, and province) generalized linear mixed models were devised for inpatient costs, revascularization odds, and length of stay (LOS). Results: 17.0% of episodes pertained to acute coronary syndrome. Median inpatient cost was PPP$2033. Interventional services accounted for the largest share of costs (37.1%). Out-of-pocket expenditure was 16.6%. Revascularization was performed in 47.2% of hospitalizations. Ambient pollution, lower socioeconomic deprivation, and higher capacity (active beds and angiography devices) were associated with provincial ICA rates. Male sex and older patients had higher revascularization odds, prolonged stays, and incurred higher costs. Procedure complexity (Cost Ratio: 4.37; 95% CI 4.34–4.39) was a major predictor of costs, along with private ownership, heart center status, and weekend hospitalization. Non-cardiac hospitalizations had prolonged LOS. Less deprived provinces had higher revascularization odds for chronic indications. Conclusions: ICA utilization, outcomes, and costs in Iran were found to be significantly associated with clinical complexity, institutional characteristics, regional capacity, and environmental exposures. These findings are critical for identifying future funding and research priorities.

  • Alignment of Research Efforts With the Diabetic Retinopathy Burden of Disease and Socioeconomic Factors: An Analytical Bibliometric Study

    by Farbod Semnani, Seyed Sahab Aarabi, Kiana Hassanpour, Payam Kabiri, Mojtaba Sedaghat, Amirhossein Takian

    Background: Diabetic retinopathy (DR) is a major microvascular complication of diabetes. Given its growing global burden and research inequities, we examined how national DR burden and socioeconomic factors relate to research interest (RI) in DR across low- and middle-income countries (LMICs) and high-income countries (HICs). Methods: We retrieved peer-reviewed DR articles published between 2018 and 2022 from Scopus. Spearman’s correlation test and multivariable linear regression were used to assess the associations between the independent variables: (a) socioeconomic factors, including health expenditure per capita purchasing power parity (PPP), current health expenditure (% of gross domestic product [GDP]), research and development (R&D) index, and human development index (HDI); (b) age-standardized years lived with disability (YLDs) rates of DR-related moderate (moderate vision impairment, MVI) and severe vision impairment (SVI) and blindness; and (c) disability-adjusted life years (DALYs) rate for diabetes, with our outcome variable, DR RI, calculated as the ratio of the number of DR publications in the field of medicine and life sciences to the whole output in the same field and country. Sensitivity analyses (2020-2022 RI vs. 2018-2019 burden) were conducted to address temporality. Results: In HICs, after adjustment for socioeconomic factors and DR-specific burden (MVI, SVI, or blindness, modeled separately), the diabetes DALY rate was the only variable independently associated with RI: MVI (β=0.56, 95% CI: 0.16 to 0.95), SVI (β=0.57, 95% CI: 0.19 to 0.94), and blindness (β=0.61, 95% CI: 0.21 to 1.02). In LMICs, no significant relationships were found between RI and MVI, SVI, blindness or diabetes DALY rates. These findings remained consistent in sensitivity analyses. Conclusion: Our research demonstrates that there is a lack of significant correlation between research efforts and the burden of DR, particularly among LMICs, which may highlight the need to strengthen research infrastructure and realign national health research priorities.

  • Top Cited Papers
    Open Access

    Prevalence, predictors, and clinical relevance of drug–drug interactions in outpatient prescribing: A national cross-sectional study

    by Seyed Sahab Aarabi, Farbod Semnani, Zahra Aminzade, Reza Mehrizi, Mohammad Gholamnezhad, Raham Armand, Nezam Armand, Leila Ghamkhar

    Background: Drug–drug interactions (DDIs) represent a major preventable cause of medication-related harm globally. Their prevalence varies across health systems, but common drivers include polypharmacy, aging populations, and specialty-specific prescribing patterns. Large-scale pharmacoepidemiologic analyses of real-world prescription data can clarify the magnitude of the problem and inform strategies to reduce risks. Methods: This retrospective study included 2,365,811 outpatient prescriptions (982,102 patients) from Tehran, Iran. The top 100 most prescribed medications were screened for potential DDIs via Micromedex®. Interactions were classified as contraindicated, major, or moderate. Logistic regression identified demographic, specialty, and prescription-level predictors. Results: Potential DDIs occurred in 46.1% of prescriptions, with 57.8% of patients affected. Major DDIs (62.6%) dominated, followed by moderate (32.8%) and contraindicated (4.6%). ASA was a frequent contributor to high-risk pairs. Contraindicated interactions were largely NSAID duplications, most common in orthopedics and emergency medicine. Psychiatry and cardiology prescriptions showed the highest prevalence, while polypharmacy strongly predicted DDIs, with incremental risks amplified in older adults. Conclusions: Outpatient DDIs represent a substantial burden in routine care, comparable to international reports. Prevention requires comprehensive strategies, including e-prescribing with CDSS, pharmacist-led reviews, patient education on OTC use, and policy interventions to limit reimbursement of unsafe combinations.


  • Open Access

    The Global Imbalance in Telemedicine Research: An Analysis of Knowledge Production and Socioeconomic Drivers

    by Seyed Sahab Aarabi, Farbod Semnani, Mojtaba Sedaghat

    Background: This study aims to explore disparities in telemedicine research, investigate the impact of the COVID-19 pandemic on these inequalities, and examine the association between various socioeconomic factors and telemedicine research output across Low- and Middle-Income Countries (LMIC) and High-Income Countries (HIC), and World Health Organization (WHO) regions. Methods: A comprehensive search strategy was developed to identify telemedicine-related documents (2018–2022) in Scopus and SciVal, with false positives and negatives resolved. Mann-Whitney U and Wilcoxon Signed Rank tests compared publication volume and Field-Weighted Citation Impact (FWCI). A novel metric, Research Interest (RI), was calculated by dividing telemedicine publications by total outputs in medicine and life sciences. WHO regions were ranked using TOPSIS. Spearman Rank Correlation assessed links between socioeconomic variables and research output separately in HIC and LMIC. Analyses were conducted using R (v4.3.2). Results: We retrieved 16,584 telemedicine-related articles: 4,244 from 58 LMIC and 13,622 from 47 HIC, including 1,282 collaborative publications (30% of LMIC and 9.4% of HIC outputs). HIC consistently produced more publications than LMIC. While FWCI differences were significant in the pre-COVID era (Cliff’s Delta = 0.48), no significant difference was observed post-COVID. RI for telemedicine showed no significant difference between HIC and LMIC in any timeframe. The Western Pacific led in quality metrics, while the Americas ranked highest overall. Southeast Asia ranked lowest in both. Exclusively among HIC, Health Expenditure (Purchasing Power Parity adjusted) (r = 0.63, r = 0.45) and Human Development Index (r = 0.50, r = 0.47) were moderately, and ICT service exports (USD) (r = 0.72, r = 0.33) were strongly correlated with both telemedicine scientific output and RI. Conclusion: Global inequalities in telemedicine research favor HIC, though the gap narrowed post-COVID. Among HIC, telemedicine research patterns more proportionately reflect socioeconomic indicators, research capacity, infrastructure, and domestic health needs.